Cite
HARVARD Citation
Purmonen, T. et al. (2019). Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis. Journal of medical economics. pp. 151-157. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Purmonen, T. et al. (2019). Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis. Journal of medical economics. pp. 151-157. [Online].